MYM Appoints New Chief Financial Officer

Vancouver, B.C., February 28, 2018 – MYM Nutraceuticals Inc., (CSE: MYM) (the “Company” or “MYM”) is pleased to announce Craig Lennox has joined MYM as its new Chief Financial Officer (CFO) effective February 26, 2018. Lennox joins MYM from Clearly, a leading online optical retailer, where he was most recently Chief Financial Officer. Lennox is Chartered Professional Accountant (CA) and brings with him an extensive background in public accounting and broad experience in financial management.

“It is an exciting time to be entering into the cannabis space and I’m pleased to be joining the MYM team to help execute in bringing the various MYM projects to market,” commented Lennox.

Lennox will lead MYM’s financial operations, and will report directly to Rob Gietl, MYM’s CEO. Craig succeeds Mark Forster who will stay on with MYM in a supporting role.

Mr. Lennox was granted 800,000 options to purchase MYM common shares, pursuant to the Company’s Stock Option Plan. The options are exercisable for a period of two years, after they vest, at a price of $1.98 per share. 200,000 of the options will vest on February 26, 2019, and 50,000 every quarter thereafter.

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products.  MYM has two production projects in Quebec that when completed will have over 1.5 million sf of production space. MYM is also a partner in a 1.2 million sf production project (Northern Rivers Project) in New South Wales, Australia. Australia is an exciting new market that has recently legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors.  MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).


Rob Gietl, CEO
MYM Nutraceuticals Inc.

Investor Relations
Terry Brown
[email protected]